Search filters

List of works by Debra Luffer-Atlas

A decade of drug metabolite safety testing: industry and regulatory shared learning

scientific article published on 11 August 2017

A radiocalibration method with pseudo internal standard to estimate circulating metabolite concentrations

scientific article published on 01 July 2010

A strategy for the risk assessment of human genotoxic metabolites

scientific article published in February 2009

Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonist

scientific article published on November 2003

Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8.

scientific article published on 11 April 2016

Evaluation in vitro and in animals of a new 11C-labeled PET radioligand for metabotropic glutamate receptors 1 in brain

scientific article published on 8 November 2012

Identification and Mitigation of Reactive Metabolites of 2-Aminoimidazole-Containing Microsomal Prostaglandin E Synthase-1 Inhibitors Terminated due to Clinical Drug-Induced Liver Injury.

scientific article published on 9 February 2018

Identification of 4-Aminopyrazolopyrimidine Metabolite That May Contribute to the Hypolipidemic Effects of LY2584702 in Long Evans Diet-Induced Obese Rats

scientific article published on 2 May 2017

Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes

scientific article published on March 1, 1998

Olaratumab exerts anti-tumor activity in preclinical models of pediatric bone and soft tissue tumors through inhibition of platelet-derived growth factor receptor &alpha

scientific article published on 30 November 2017

Overview of metabolite safety testing from an industry perspective

scientific article published on July 2010

PDGFRα monoclonal antibody: Assessment of embryo-fetal toxicity and time-dependent placental transfer of a murine surrogate antibody of olaratumab in mice

scientific article published on 27 October 2018

Population Pharmacokinetic Modeling of Olaratumab, an Anti-PDGFRα Human Monoclonal Antibody, in Patients with Advanced and/or Metastatic Cancer

scientific article published on 15 June 2017

Predicting circulating human metabolites: how good are we?

scientific article published in February 2009

Serum Lipid and Protein Changes in Healthy Dyslipidemic Subjects Given a Selective Inhibitor of p70 S6 Kinase-1.

scientific article published on 26 November 2017

The early estimation of circulating drug metabolites in humans

scientific article published on June 10, 2012

The effect of hepatic or renal impairment on the pharmacokinetics of edivoxetine, a selective norepinephrine transporter reuptake inhibitor

scientific article published on 17 August 2013

Unique/major human metabolites: why, how, and when to test for safety in animals

scientific article published on 01 January 2008